Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

Cited by (1,001)

Items 501–600 of 1,001

1. Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products
   Khumoekae Richard, David E. Williams, E. Dilip de Silva, Mark A. Brockman, Zabrina L. Brumme, Raymond J. Andersen, Ian Tietjen · 2018 · Viruses
2. HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy
   Rachel L. Miller, Rosalie Ponte, Bradley R. Jones, Natalie N. Kinloch, F. Harrison Omondi, Mohammad-Ali Jenabian, Franck P. Dupuy, Rémi Fromentin, Pierre Brassard, Vikram Mehraj et al. · 2019 · Journal of Virology
3. Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
   Jessica M. Conway, Alan S. Perelson, Jonathan Z. Li · 2019 · PLoS Computational Biology
4. Elimination of infectious HIV DNA by CRISPR–Cas9
   Atze T. Das, Caroline S. Binda, Ben Berkhout · 2019 · Current Opinion in Virology
5. HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities
   Corbin G. Thompson, Cynthia L. Gay, Angela D. M. Kashuba · 2017 · AIDS Research and Human Retroviruses
6. CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency
   Gilles Darcis, Neeltje A. Kootstra, Berend Hooibrink, Thijs van Montfort, Irma Maurer, Kevin Groen, Suzanne Jurriaans, Margreet E. Bakker, Carine M. Van Lint, Ben Berkhout et al. · 2020 · Cell Reports
7. CRISPR /Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity
   Iraj Mohammadzadeh, Durdi Qujeq, Tooba Yousefi, Gordon A. Ferns, Mahmood Maniati, Mostafa Vaghari‐Tabari · 2020 · IUBMB Life
8. Gb Virus C Infection is Associated with a Reduced Rate of Reactivation of Latent HIV and Protection against Activation-Induced T-Cell Death
   Robert T. Rydze, Nirjal Bhattarai, Jack T. Stapleton · 2012 · Antiviral Therapy
9. Modulation of apoptosis and viral latency – an axis to be well understood for successful cure of human immunodeficiency virus
   Uddhav Timilsina, Ritu Gaur · 2016 · Journal of General Virology
10. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection
    Catherine DeMarino, Angela Schwab, Michelle L. Pleet, Allison H. Mathiesen, Joel M. Friedman, Nazira El‐Hage, Fatah Kashanchi · 2016 · Journal of Neuroimmune Pharmacology
11. Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells
    John K. Bui, Elias Konstantine Halvas, Elizabeth Fyne, Michele D. Sobolewski, Dianna L. Koontz, Wei Shao, Brian T. Luke, Feiyu F. Hong, Mary F. Kearney, John W. Mellors · 2017 · PLoS Pathogens
12. Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
    Z Huang, Asahi Tomitaka, Andrea Raymond, Madhavan Nair · 2017 · Gene Therapy
13. Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals
    Elizabeth R. Wonderlich, Krupa Subramanian, Bryan D. Cox, Ann P. Wiegand, Carol Lackman-Smith, Michael J. Bale, Mars Stone, Rebecca Hoh, Mary F. Kearney, Frank M. Maldarelli et al. · 2019 · PLoS Pathogens
14. Hexamethylbisacetamide Remodels the Human Immunodeficiency Virus Type 1 (HIV-1) Promoter and Induces Tat-Independent HIV-1 Expression but Blunts Cell Activation
    Vladimir I. Klichko, Nancy M. Archin, Rupinderjeet Kaur, Ginger K. Lehrman, David M. Margolis · 2006 · Journal of Virology
15. Molecular mechanisms of HIV-1 proviral latency
    Dwayne A. Bisgrove, Mary K. Lewinski, Frederic D. Bushman, Eric M. Verdin · 2005 · Expert Review of Anti-infective Therapy
16. Distinct gene expression by expanded clones of quiescent memory CD4+ T cells harboring intact latent HIV-1 proviruses
    Georg H.J. Weymar, Yotam Bar‐On, Thiago Y. Oliveira, Christian Gaebler, Víctor Ramos, Harald Hartweger, Gaëlle Breton, Marina F. Caskey, Lillian B. Cohn, Mila Janković et al. · 2022 · Cell Reports
17. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels
    William J. Hey-Cunningham, John M. Murray, Ven Natarajan, Janaki Amin, Cecilia L. Moore, Sean Emery, David A. Cooper, John Zaunders, Anthony Dominic Kelleher, Kersten K. Koelsch · 2015 · AIDS
18. IL-7 as a potential therapy for HIV-1-infected individuals
    Giuseppe Nunnari, Roger J. Pomerantz · 2005 · Expert Opinion on Biological Therapy
19. The immunological synapse: the gateway to the HIV reservoir
    Deanna A. Kulpa, Jessica H. Brehm, Rémi Fromentin, Anthony B. Cooper, Colleen Cooper, Jeffrey D. Ahlers, Nicolas Chomont, Rafick‐Pierre Sékaly · 2013 · Immunological Reviews
20. Effect of the Latent Reservoir on the Evolution of HIV at the Within- and Between-Host Levels
    Hilje M. Doekes, Christophe Fraser, Katrina Lythgoe · 2017 · PLoS Computational Biology
21. HIV integration sites and implications for maintenance of the reservoir
    Jori Symons, Paul U. Cameron, Sharon R. Lewin · 2017 · Current Opinion in HIV and AIDS
22. Sanger and Next Generation Sequencing Approaches to Evaluate HIV-1 Virus in Blood Compartments
    Andrea Arias, Pablo Luis López, Raphael Sánchez, Yasuhiro Yamamura, Vanessa Rivera‐Amill · 2018 · International Journal of Environmental Research and Public Health
23. HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals
    Julia Sung, Shabnum Patel, Matthew L. Clohosey, Lauren Roesch, Tamara Tripic, JoAnn D. Kuruc, Nancie M. Archin, Patrick J. Hanley, Carolina Colli Cruz, Nilu P Goonetilleke et al. · 2018 · Molecular Therapy
24. Targeting Immune Checkpoint Molecules to Eliminate Latent HIV
    Zoe Boyer, Sarah Palmer · 2018 · Frontiers in Immunology
25. CD32 + and PD-1 + Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals
    Alessandra Noto, Francesco A. Procopio, Riddhima Banga, Madeleine Suffiotti, Jean-Marc Corpataux, Matthias L. Cavassini, Agostino Riva, Craig W. Fenwick, Raphaël Gottardo, Matthieu Perreau et al. · 2018 · Journal of Virology
26. Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections
    Elizabeth M. Anderson, Francesco Roberto Simonetti, Robert J. Gorelick, Shawn Hill, Monica A. Gouzoulis, Jennifer Bell, Catherine A. Rehm, Liliana Pérez, Eli Boritz, Xiaolin Wu et al. · 2020 · Viruses
27. Benefits and limitations of humanized mice in HIV persistence studies
    Matthew D. Marsden · 2020 · Retrovirology
28. HIV reservoir quantification using cross-subtype multiplex ddPCR
    Noah A.J. Cassidy, Carolyn S. Fish, Claire Levy, Pavitra Roychoudhury, Daniel B. Reeves, Sean M. Hughes, Joshua Tisdell Schiffer, Sarah F. Benki-Nugent, Grace C. John-Stewart, Dalton C. Wamalwa et al. · 2021 · iScience
29. Long-Lasting Decrease in Viremia in Macaques Chronically Infected with Simian Immunodeficiency Virus SIVmac251 after Therapeutic DNA Immunization
    Agneta S. von Gegerfelt, Margherita Rosati, Candido Alicea, Antonio Valentin, Patricia Roth, Jenifer Bear, Genoveffa Franchini, Paul S. Albert, Norbert Bischofberger, Jean Boyer et al. · 2006 · Journal of Virology
30. Phylogenetics and Phyloanatomy of HIV/SIV Intra-Host Compartments and Reservoirs: The Key Role of the Central Nervous System
    Marco Salemi, Brittany Rife Magalis · 2015 · Current HIV Research
31. Apoptosis-induced activation of HIV-1 in latently infected cell lines
    Sohrab Zafar Khan, Nicholas J. Hand, Steven L. Zeichner · 2015 · Retrovirology
32. Dendritic Cell-induced Activation of Latent HIV-1 Provirus in Actively Proliferating Primary T Lymphocytes
    Renée Marije van der Sluis, Thijs van Montfort, Georgios Pollakis, Rogier W. Sanders, Dave Speijer, Ben Berkhout, Rienk E. Jeeninga · 2013 · PLoS Pathogens
33. The role of latency reversal agents in the cure of HIV: A review of current data
    Kiandokht Bashiri, Nima Rezaei, Milena Nasi, Andrea Cossarizza · 2018 · Immunology Letters
34. Principles Governing Establishment versus Collapse of HIV-1 Cellular Spread
    Jason M. Hataye, Joseph Paul Casazza, Katharine Best, C. Jason Liang, Taina T. Immonen, David R. Ambrozak, Samuel W. Darko, Amy R. Henry, Farida Laboune, Frank M. Maldarelli et al. · 2019 · Cell Host & Microbe
35. The Use of CRISPR/Cas9 as a Tool to Study Human Infectious Viruses
    Huafeng Lin, Gang Li, Xiangwen Peng, Aimin Deng, Lei Ye, Lei Shi, Tuanmei Wang, Jun He · 2021 · Frontiers in Cellular and Infection Microbiology
36. Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells
    Hiroshi Takata, Juyeon C. Kakazu, Julie L. Mitchell, Eugene D. M. B. Kroon, Donn J. Colby, Carlo Sacdalan, Hongjun Bai, Philip K. Ehrenberg, Aviva Geretz, Supranee Buranapraditkun et al. · 2022 · EBioMedicine
37. Impact of misclassified defective proviruses on HIV reservoir measurements
    Daniel B. Reeves, Christian Gaebler, Thiago Y. Oliveira, Michael J. Peluso, Joshua Tisdell Schiffer, Lillian B. Cohn, Steven G. Deeks, Michel C. Nussenzweig · 2023 · Nature Communications
38. Identification of Nevirapine‐Resistant HIV‐1 in the Latent Reservoir after Single‐Dose Nevirapine to Prevent Mother‐to‐Child Transmission of HIV‐1
    Megan Wind‐Rotolo, Christine M. Durand, Lisa Marie Cranmer, Alison P. Reid, Neil Alexander Martinson, Meg C. Doherty, Benjamin L. Jilek, Joseph Kagaayi, Allan Kizza, Visva Pillay et al. · 2009 · The Journal of Infectious Diseases
39. Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART
    Riddhima Banga, Francesco A. Procopio, Erica Lana, Gregory T. Gladkov, Isabelle C. Roseto, Elizabeth M. Parsons, Xiaodong Lian, Marie Armani-Tourret, Maxime Bellefroid, Ce Gao et al. · 2023 · Cell Host & Microbe
40. The multifaceted nature of HIV tissue reservoirs
    Riddhima Banga, Matthieu Perreau · 2024 · Current Opinion in HIV and AIDS
41. Rapid Turnover of 2-LTR HIV-1 DNA during Early Stage of Highly Active Antiretroviral Therapy
    Weijun Zhu, Yanmei Jiao, Rongyue Lei, Wei Hua, Rui Wang, Yunxia Ji, Zhiying Liu, Feili Wei, Tong Zhang, Xuanlin Shi et al. · 2011 · PLoS ONE
42. Contribution of Follicular Dendritic Cells to Persistent HIV Viremia
    Jingshan Zhang, Alan S. Perelson · 2013 · Journal of Virology
43. Standard vaccines increase HIV-1 transcription during antiretroviral therapy
    Christina Yek, Sara Gianella, Montserrat Plana, Pedro Castro, Konrad Scheffler, Felipe García, Marta Massanella, Davey Mitchell Smith · 2016 · AIDS
44. Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies
    Timothy J. Henrich, Steven G. Deeks, Satish K. Pillai · 2017 · The Journal of Infectious Diseases
45. Hybrid nanocarriers incorporating mechanistically distinct drugs for lymphatic CD4 + T cell activation and HIV-1 latency reversal
    Shijie Cao, Sarah Danielle Slack, Claire Levy, Sean M. Hughes, Yonghou Jiang, Christopher Yogodzinski, Pavitra Roychoudhury, Keith R. Jerome, Joshua Tisdell Schiffer, Florian Hladik et al. · 2019 · Science Advances
46. Despite early antiretroviral therapy effector memory and follicular helper CD4 T cells are major reservoirs in visceral lymphoid tissues of SIV-infected macaques
    Henintsoa Rabezanahary, Félicien Moukambi, David Palesch, Julien A. Clain, Gina Racine, Guadalupe Andreani, Ghita Benmadid-Laktout, Ouafa Zghidi‐Abouzid, Calayselvy Soundaramourty, Cecile L. Tremblay et al. · 2019 · Mucosal Immunology
47. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
    Hadega Aamer, Jan McClure, Daisy L. Ko, Janine R. Maenza, Ann C. Collier, Robert W. Coombs, James I. Mullins, Lisa M. Frenkel · 2020 · PLoS Pathogens
48. Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach
    Chaolong Qin, Yenju Chu, Wanshan Feng, Christophe Fromont, Sijia He, Joseph Ali, Jong Bong Lee, Atheer Zgair, Mattia Berton, Sara Bettonte et al. · 2020 · Journal of Controlled Release
49. A unified concept of HIV latency
    Omar Bagasra · 2006 · Expert Opinion on Biological Therapy
50. Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained
    Marilia Rita Pinzone, Una O’Doherty · 2018 · Retrovirology
51. Stable gene expression occurs from a minority of integrated HIV-1-based vectors: transcriptional silencing is present in the majority
    Hoi Ping Mok, Sajid Javed, Andrew M. L. Lever · 2007 · Gene Therapy
52. CBX4 contributes to HIV‐1 latency by forming phase‐separated nuclear bodies and SUMOylating EZH2
    Liyang Wu, Ting Shuang Pan, Mo Zhou, Tao Chen, Shiyu Wu, Xi Lv, Jun Liu, Fei Yu, Yuanjun Guan, Bingfeng Liu et al. · 2022 · EMBO Reports
53. An ordeal that does not heal: understanding barriers to a cure for HIV-1 infection
    Mathias D. Lichterfeld, Ce Gao, Xu G. Yu · 2022 · Trends in Immunology
54. Molecular Understanding of HIV-1 Latency
    Wasim Abbas, Georges Herbein · 2012 · Advances in Virology
55. T-Cell Signaling in HIV-1 Infection
    Wasim Abbas, Georges Herbein · 2013 · The Open Virology Journal
56. Therapeutic vaccines and immunological intervention in HIV infection
    Giuseppe Pantaleo, Yves Lévy · 2016 · Current Opinion in HIV and AIDS
57. Innate, non-cytolytic CD8+ T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription
    Michelle Zanoni, David Palesch, Claudia Pinacchio, Maura Statzu, Gregory K. Tharp, Mirko Paiardini, Ann Chahroudi, Steven E. Bosinger, Jack Yoon, Bryan D. Cox et al. · 2020 · PLoS Pathogens
58. Implications of the accumulation of CXCR5+ NK cells in lymph nodes of HIV-1 infected patients
    An-Liang Guo, Yan‐Mei Jiao, Qiwen Zhao, Hui-Huang Huang, Jianning Deng, Chao Zhang, Xing Fan, Ruonan Xu, Ji‐Yuan Zhang, Cheng Zhen et al. · 2021 · EBioMedicine
59. The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells
    Miranda Shehu-Xhilaga, David Rhodes, Fiona Wightman, H. B. Liu, Ajantha E. Solomon, Suha M. Saleh, Anthony E. Dear, Paul U. Cameron, Sharon R. Lewin · 2009 · AIDS
60. Mathematical Models of HIV Latency
    Alison L. Hill · 2017 · Current topics in microbiology and immunology
61. HIV persistence: silence or resistance?
    Alexander O. Pasternak, Ben Berkhout · 2023 · Current Opinion in Virology
62. Global, regional and national burden of HIV/AIDS among individuals aged 15-79 from 1990 to 2021
    Yuanfang Chen, An-Dong Li, Yizhou Yang, Jing Lu, Yu Xu, Xinyu Ji, Liting Wu, Lei Han, Baoli Zhu, Ming Xu · 2025 · AIDS Research and Therapy
63. Selective Histonedeacetylase Inhibitor M344 Intervenes in HIV-1 Latency through Increasing Histone Acetylation and Activation of NF-kappaB
    Hao Ying, Yuhao Zhang, Xin Zhou, Xiying Qu, Pengfei Wang, Sijie Liu, Daru Lu, Huanzhang Zhu · 2012 · PLoS ONE
64. Pharmaceutical approaches to eradication of persistent HIV infection
    Mary Catherine Bowman, Nancie M. Archin, David M. Margolis · 2009 · Expert Reviews in Molecular Medicine
65. New insights in the role of nucleoporins: a bridge leading to concerted steps from HIV-1 nuclear entry until integration.
    F. Di Nunzio · 2013 · Virus Research
66. Therapeutic vaccination for HIV
    Kathryn E. Stephenson · 2018 · Current Opinion in HIV and AIDS
67. Establishment of a Novel Humanized Mouse Model To Investigate In Vivo Activation and Depletion of Patient-Derived HIV Latent Reservoirs
    Nina C. Flerin, Ariola Bardhi, Jian Hua Zheng, Maria Korom, Joy M. Folkvord, Colin M Kovacs, Erika Benko, Ronald Truong, Talia M. Mota, Elizabeth Connick et al. · 2019 · Journal of Virology
68. Broadly neutralizing antibodies and vaccine design against HIV-1 infection
    Qian Wang, Linqi Zhang · 2019 · Frontiers of Medicine
69. Epigenetic Suppression of HIV in Myeloid Cells by the BRD4-Selective Small Molecule Modulator ZL0580
    Edrous Alamer, Chaojie Zhong, Zhiqing Liu, Qingli Niu, Fuquan Long, Lulu Guo, Benjamin B. Gelman, Lynn Soong, Jia Zhou, Haitao Hu · 2020 · Journal of Virology
70. Modeling of the HIV-1 Life Cycle in Productively Infected Cells to Predict Novel Therapeutic Targets
    Olga Shcherbatova, Dmitry Sergeevich Grebennikov, IGOR A. SAZONOV, Andreas Meyerhans, Gennady Alekseevich Bocharov · 2020 · Pathogens
71. Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients
    Marianne Burgard, Faroudy Boufassa, Jean‐Paul Viard, Isabelle Garrigue, Annick Ruffault, Jacques Izopet, Astrid Vabret, Diane Descamps, Philippe Colson, Jean‐Marie Seigneurin et al. · 2009 · AIDS
72. The latent reservoir for HIV-1 in resting CD4+ T cells and other viral reservoirs during chronic infection: insights from treatment and treatment-interruption trials
    Christine M. Haggerty, Eleanor Pitt, Robert F. Siliciano · 2006 · Current Opinion in HIV and AIDS
73. Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations
    Grissell Tirado, Gloria Jove, Rakesh K. Kumar, Richard J. Noel, Evelyn Reyes, Gladys E. Sepulveda, Y Yamamura, Anil Kumar · 2004 · Virology
74. The role of HIV integration in viral persistence: no more whistling past the proviral graveyard
    Frank M. Maldarelli · 2016 · Journal of Clinical Investigation
75. Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C–induced HIV latency reversal
    Kouki Matsuda, Takuya Kobayakawa, Kiyoto Tsuchiya, Shin-ichiro Hattori, Wataru Nomura, Hiroyuki Gatanaga, Kazuhisa Yoshimura, Shinichi Oka, Yasuyuki Endo, Hirokazu Tamamura et al. · 2018 · Journal of Biological Chemistry
76. Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials
    Daniel B. Reeves, Yunda Huang, Elizabeth R. Duke, Bryan T. Mayer, Erwing Fabian Cardozo Ojeda, Florencia A. T. Boshier, David A. Swan, Morgane Rolland, Merlin Lee Robb, John R. Mascola et al. · 2020 · PLoS Computational Biology
77. T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy
    Gila Lustig, Sandile Cele, Farina Karim, Anne Derache, Abigail Ngoepe, Khadija Khan, Bernadett Isabel Gosnell, Mahomed‐Yunus S. Moosa, Ntombi Ntshuba, Suzaan Marais et al. · 2021 · PLoS Pathogens
78. Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques
    Victoria E. K. Walker-Sperling, Noe B. Mercado, Abishek Chandrashekar, Erica N. Borducchi, Jinyan Liu, Joseph P. Nkolola, Mark G. Lewis, Jeffrey P. Murry, Yunling Yang, Romas Geleziunas et al. · 2022 · Nature Communications
79. Mathematical Modelling of Biosystems
    Rubem P Mondaini, Pãnos M. Pardalos · 2008 · Springer eBooks
80. Chromatin-Associated Regulation Of Hiv-1 Transcription
    Vincent Quivy, Stéphane de Walque, Carine M. Van Lint · 2007 · Sub-cellular biochemistry/Subcellular biochemistry
81. Persistent HIV Type 1 Infection in Semen and Blood Compartments in Patients after Long-Term Potent Antiretroviral Therapy
    Jodi K. Craigo, Bruce Kendrick Patterson, Shirish Paranjpe, Kathy Kulka, Ming Ding, John W. Mellors, Ronald C. Montelaro, Phalguni Gupta · 2004 · AIDS Research and Human Retroviruses
82. A Novel Assay Allows Genotyping of the Latent Reservoir for Human Immunodeficiency Virus Type 1 in the Resting CD4+T Cells of Viremic Patients
    Daphne Monie, Rachel P. Simmons, Richard E. Nettles, Tara L. Kieffer, Yan Zhou, Haili Zhang, Sharon L. Karmon, Roxann Ingersoll, Karen R. Chadwick, Hao Zhang et al. · 2005 · Journal of Virology
83. Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial
    Deepti Saxena, Michael Spino, Fernando Tricta, John Connelly, Bernadette M. Cracchiolo, Axel-Rainer Hanauske, Darlene D’Alliessi Gandolfi, Michael B. Mathews, Jonathan Karn, Bart K. Holland et al. · 2016 · PLoS ONE
84. Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy
    Sunpeng Wang, Libin Rong · 2014 · Journal of Theoretical Biology
85. Effect of therapeutic HIV recombinant poxvirus vaccines on the size of the resting CD4+ T-cell latent HIV reservoir
    Deborah Persaud, Katherine Luzuriaga, Carrie Ziemniak, Petronella Muresan, Thomas C. Greenough, Terry Fenton, Amanda L. Blackford, Kimberly C. Ferguson, Natalie M. Neu, Coleen K. Cunningham · 2011 · AIDS
86. Therapeutics for HIV-1 reactivation from latency
    Marco Sgarbanti, Angela Battistini · 2013 · Current Opinion in Virology
87. Novel Pathway for Induction of Latent Virus from Resting CD4+T Cells in the Simian Immunodeficiency Virus/Macaque Model of Human Immunodeficiency Virus Type 1 Latency
    Anding Shen, Hung‐Chih Yang, Yan Zhou, Amanda J. Chase, Jean Boyer, Hao Zhang, Joseph B. Margolick, M. Christine Zink, Janice E. Clements, Robert F. Siliciano · 2006 · Journal of Virology
88. Replication-Competent Simian Immunodeficiency Virus (SIV) Gag Escape Mutations Archived in Latent Reservoirs during Antiretroviral Treatment of SIV-Infected Macaques
    Suzanne E. Queen, Brian M. Mears, Kathleen M. Kelly, Jamie L. Dorsey, Zhaohao Liao, Jason B. Dinoso, Lúcio Gama, Robert J. Adams, M. Christine Zink, Janice E. Clements et al. · 2011 · Journal of Virology
89. Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study
    Annica Lindkvist, Arvid Edén, Melissa M. Norström, Veronica D. Gonzalez, Staffan Nilsson, Bo Svennerholm, Annika C. Karlsson, Johan K. Sandberg, Anders B. Sönnerborg, Magnus Gisslén · 2009 · AIDS Research and Therapy
90. Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells
    Lachlan R. Gray, Hung On, Emma Roberts, Hao Kim Lu, Michael A. Moso, Jacqueline A. Raison, Catherine Papaioannou, Wan‐Jung Cheng, Anne M. Ellett, Jonathan C. Jacobson et al. · 2016 · Journal of NeuroVirology
91. Post-Treatment Controllers: Role in HIV “Cure” Research
    Leslie R. Cockerham, Hiroyu Hatano, Steven G. Deeks · 2016 · Current HIV/AIDS Reports
92. A highly reproducible quantitative viral outgrowth assay for the measurement of the replication-competent latent HIV-1 reservoir
    Axel Fun, Hoi Ping Mok, Mark R. Wills, Andrew M. L. Lever · 2017 · Scientific Reports
93. Pharmacologic HIV-1 Nef blockade promotes CD8 T cell–mediated elimination of latently HIV-1–infected cells in vitro
    Shariq Mujib, Aamir Saiyed, Saleh Fadel, Ardalan Bozorgzad, Nasra Aidarus, Feng Yun Yue, Erika Benko, Colin C. Kovacs, Lori A. Emert‐Sedlak, Thomas E. Smithgall et al. · 2017 · JCI Insight
94. Assessment of metabolic and mitochondrial dynamics in CD4+ and CD8+ T cells in virologically suppressed HIV-positive individuals on combination antiretroviral therapy
    Jesse J. R. Masson, Andrew James Murphy, Man K.S. Lee, Matías Ostrowski, Suzanne M. Crowe, Clovis Steve Palmer · 2017 · PLoS ONE
95. Follicular CD8+ T Cells: Origin, Function and Importance during HIV Infection
    Federico Perdomo-Celis, Natalia A. Taborda, Marı́a Teresa Rugeles · 2017 · Frontiers in Immunology
96. Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression
    Ramla Fatime Tanko, Andreia P. Soares, Lindi Masson, Nigel Garrett, Natasha Samsunder, Quarraisha Abdool Karim, Salim S. Abdool Karim, Catherine Riou, Wendy A. Burgers · 2018 · Clinical Immunology
97. Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice
    Thomas D. Norton, Anjie Zhen, Takuya Tada, Jennifer S. Kim, Scott G. Kitchen, Nathaniel Roy Landau · 2019 · Molecular Therapy
98. CRISPR-Cas system: from diagnostic tool to potential antiviral treatment
    Aishwarya Rajan, Stuti Shrivastava, Janhawi, Akhilesh Kumar, Alok Kumar Singh, Pankaj Kumar Arora · 2022 · Applied Microbiology and Biotechnology
99. Lessons From HIV Therapy Applied to Viral Hepatitis Therapy: Summary of a Workshop
    Alexander Monto, Robert Turner Schooley, Jennifer C. Lai, Mark Sulkowski, Raymond T. Chung, Jean–Michel Pawlotsky, John G. McHutchison, Ira M. Jacobson · 2010 · The American Journal of Gastroenterology
100. Persistent Abnormalities in Peripheral Blood Dendritic Cells and Monocytes from HIV-1-Positive Patients After 1 Year of Antiretroviral Therapy
     Maria das Graças Almeida, Miguel Cordero, Júlia Almeida, Alberto Órfão · 2006 · JAIDS Journal of Acquired Immune Deficiency Syndromes